retatrutide phase 2 Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized 2a trial Does Retatrutide Make You Lose

Patients using oral birth control should consider adding a barrier method or switching to a non-oral contraceptive option (such as an IUD or implant) for at least four weeks after starting Zepbound and after each dose increase

What to Expect During the Treatment: A CoolSculpting applicator is placed on the treatment area (typically under the chin or along the jawline)

D.BergerN

Clinical evidence supports modest improvements in hair density and thickness with consistent use, typically three to four sessions per week for 15-25 minutes each

Prem J Sci 2025;10:100082

TIRZEPATIDE is a dual agonist that acts on both the GIP (glucose-dependent insulinotropic polypeptide) receptor and the GLP-1 receptor